DiscussWorldIssues - Socio-Economic Religion and Political Uncensored Debate - View Single Post

**jenilopaz** · 09-27-2010, 12:48 AM

This is what Palin described and was rudely attacked for. The death panels in American government are real. They will decide if your life is worth the money.
Say goodbye to Grandma right now. She's as good as dead....

http://www.usatoday.com/yourlife/hea...terstitialskip

$93,000 cancer drug: How much are a few months of life worth?

By Marilynn Marchione, The Associated Press

BOSTON — Cancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth.
The latest is Provenge, a first-of-a-kind therapy approved in April. It costs $93,000 and adds four months' survival, on average, for men with incurable prostate tumors. Bob Svensson is honest about why he got it: insurance paid...

His supplemental Medicare plan is paying while the government decides whether basic Medicare will cover Provenge and for whom. The tab for taxpayers could be huge — prostate is the most common cancer in American men. Most of those who have it will be eligible for Medicare, and Provenge will be an option for many late-stage cases. A meeting to consider Medicare coverage is set for Nov. 17.

09-27-2010, 12:48 AM	#1
jenilopaz Join Date Oct 2005 Posts 399 Senior Member	Here's your death panels, bitches! This is what Palin described and was rudely attacked for. The death panels in American government are real. They will decide if your life is worth the money. Say goodbye to Grandma right now. She's as good as dead.... http://www.usatoday.com/yourlife/hea...terstitialskip $93,000 cancer drug: How much are a few months of life worth? By Marilynn Marchione, The Associated Press BOSTON — Cancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth. The latest is Provenge, a first-of-a-kind therapy approved in April. It costs $93,000 and adds four months' survival, on average, for men with incurable prostate tumors. Bob Svensson is honest about why he got it: insurance paid... His supplemental Medicare plan is paying while the government decides whether basic Medicare will cover Provenge and for whom. The tab for taxpayers could be huge — prostate is the most common cancer in American men. Most of those who have it will be eligible for Medicare, and Provenge will be an option for many late-stage cases. A meeting to consider Medicare coverage is set for Nov. 17.
	Quote